Patent ID: 9572792
Date: 2017-02-21
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method of treating a disorder associated with sphingosine-1-phosphate 1 (S1P1) receptor modulation, the method comprising administering to a mammal in need thereof a pharmaceutical composition comprising a therapeutically effective amount of a compound of Formula I: wherein: R R R R R R R a is 1 or 2; b is 2 or 3; c is 0 or 1; d is 0 or 1; e is 0 or 1; f is 0 or 1; g is 2 or 3; R R R R R R R R R R R R R R wherein each said alkyl is optionally substituted with halogen, hydroxyl, cycloalkyl, amino, non-aromatic heterocycle, carboxylic acid, phosphonic acid, sulphonic acid or phosphoric acid, unless otherwise specified; or an enantiomer, diastereoisomer, hydrate, solvate, crystal form, isomer or tautomer thereof; or a pharmaceutically acceptable salt of any of the foregoing, wherein the disorder is selected from the group consisting of inflammatory bowel disease and ulcerative colitis.